Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.460
-0.150 (-5.75%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Xenetic Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Xenetic Biosciences.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Xenetic Biosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2023 |
Financial Forecast
Revenue This Year
1.84M
from 2.50M
Decreased by -26.57%
Revenue Next Year
2.35M
from 1.84M
Increased by 27.78%
EPS This Year
-3.30
from -2.57
EPS Next Year
-0.46
from -3.30
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 1.9M | 2.4M |
Avg | 1.8M | 2.3M |
Low | 1.8M | 2.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | -24.4% | 31.5% |
Avg | -26.6% | 27.8% |
Low | -29.4% | 22.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -3.40 | -0.47 | -0.57 |
Avg | -3.30 | -0.46 | -0.55 |
Low | -3.18 | -0.44 | -0.53 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.